The Crypto Basic
Moderna stock more than doubled at its premarket peak Wednesday after the company’s personalized mRNA cancer treatment, developed with Merck, succeeded in a pivotal Phase 3 melanoma trial. MRNA rose…
Related articles
-
Circle Is Mispriced as Stablecoins March Toward Trillions, Says Bitwise Analyst
BlockchainReporter Published 11.08.2026 03:00
-
OpenAI Halts Astra AI Development Over Autonomous Hacking Concerns
Blocknomi Published 08.08.2026 11:50
-
Ethereum study flags 65,340 risky addresses tied to $574.8M
Crypto.News Published 14.08.2026 05:08
-
Ether.fi Separates Restaking From weETH as Staking Risk Debate Grows
Crypto Daily Published 10.08.2026 10:01
-
Zcash (ZEC) Breaks Out Unexpectedly as Key Golden EMA Cross Occurs
U.Today Published 18.08.2026 08:00
-
Bitcoin-Gold Correlation Spikes on Macro Risks; Shiba Inu (SHIB) Whale Presence Shrinks to Just 0.04%; Binance Secures $600 Million Tokenization Milestone: Founder Reacts — Morning Crypto Report
U.Today Published 12.08.2026 12:46
-
City of Baltimore goes after prediction markets for sports betting
Cointelegraph Published 13.08.2026 21:08
-
SharpLink CEO warns EIP-8363 could kill ETH’s biggest advantage over Bitcoin
The Block Published 07.08.2026 19:37